Evidence map›Paper›PMID 19931357›Full record

ArticleNeuroscience2010

Nociceptor subpopulations involved in hyperalgesic priming.

L F Ferrari, O Bogen, J D Levine

Open access · greenAbstract read
In one paragraph

Article in Neuroscience, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 89 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. The Nociceptor Primary Cilium Contributes to Mechanical Nociceptive Threshold and Inflammatory and Neuropathic Pain.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Neuropathic pain; what we know and what we should do about it.Frontiers in pain research (Lausanne, Switzerland) · 2023
    Review
  9. Review
  10. Review
  11. Preventing the induction of acid saline-induced fibromyalgia pain in mice by electroacupuncture or APETx2 injection.Acupuncture in medicine : journal of the British Medical Acupuncture Society · 2020
    Article
  12. The Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
  13. Article
  14. Article
  15. Article
  16. Swedish Nerve Growth Factor Mutation (NGFThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

L F FerrariDivision of Neuroscience, Departments of Medicine and Oral and Maxillofacial Surgery, University of California, 521 Parnassus Avenue, San Francisco, CA 94143-0440, USA.
O Bogen
J D Levine
University of California, San Francisco · US

Funding

Receptors and Second Messengers for Pain and AnalgesiaP01NS053709 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LEVINE, JON DAVID · 2007 to 2011
$5.0M
Role of Subdiaphragmatic Vagus in Fibromyalgia SyndromeR01AR048821 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LEVINE, JON DAVID · 2004 to 2013
$2.8M
Mechanisms of Interactions of Alcohol Abuse HIV NeuropathogenesisR01AA017384 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LEVINE, JON DAVID · 2008 to 2012
$1.7M
Mechanisms and Risk Factors in Musculoskeletal PainR01AR054635 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LEVINE, JON DAVID · 2007 to 2011
$1.6M
Sex dimorphism in neuroendocrine control of inflammationR01AR052106 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LEVINE, JON DAVID · 2006 to 2010
$1.5M
Integrin family of proteins in acute and chronic painR01NS053880 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LEVINE, JON DAVID · 2006 to 2009
$1.4M
NIAAA NIH HHS R01 AA017384NIAMS NIH HHS AR048821NIAMS NIH HHS AR052106NIAMS NIH HHS R01 AR048821NIAMS NIH HHS R01 AR054635NINDS NIH HHS NS053709NINDS NIH HHS NS053880NINDS NIH HHS R01 NS053880
6 · The paper itself

Abstract

We have previously developed a model in the rat for the transition from acute to chronic pain, hyperalgesic priming, in which a long-lasting neuroplastic change in signaling pathways mediates a prolongation of proinflammatory cytokine-induced nociceptor sensitization and mechanical hyperalgesia, induced at the site of a previous inflammatory insult. Induction of priming is mediated by activation of protein kinase C(epsilon) (PKC(epsilon)) in the peripheral terminal of the primary afferent nociceptor. Given that hyperalgesic mediator-induced PKC(epsilon) translocation occurs in isolectin B4 (IB4)(+)-nonpeptidergic but not in receptor tyrosine kinase (TrkA)(+)-peptidergic nociceptors, we tested the hypothesis that hyperalgesic priming was restricted to the IB4(+) subpopulation of nociceptors. After recovery from nerve growth factor (NGF)- and GDNF-induced hyperalgesia, a proinflammatory cytokine, prostaglandin E(2) (PGE(2)) induced, PKC(epsilon)-dependent, markedly prolonged hyperalgesia, two features that define the development of the primed state. Thus, hyperalgesic priming occurs in both the IB4(+)-nonpeptidergic and TrkA(+)-peptidergic subpopulations of nociceptive afferents. Of note, however, while attenuation of PKC(epsilon) prevented NGF-induced priming, the hyperalgesia induced by NGF is PKC(epsilon) independent. We propose that separate intracellular pools of PKC(epsilon), in the peripheral terminals of nociceptors, mediate nociceptor sensitization and the induction of hyperalgesic priming.

Indexed as

AnimalsDinoprostoneGene Knockdown TechniquesGlial Cell Line-Derived Neurotrophic FactorHyperalgesiaLectinsMaleNerve Growth FactorNociceptorsPain MeasurementProtein Kinase C-epsilonRatsRats, Sprague-DawleyReceptor, trkATime FactorsDinoprostoneGlial Cell Line-Derived Neurotrophic FactorLectinsNerve Growth FactorProtein Kinase C-epsilonReceptor, trkA

Identifiers

PMID19931357
PMCPMC2815163
OpenAlexW2074446731

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.